Holen Sie sich die Stockscreener-App
7.0289
1.65%
-0.1011
Schlusskurs vom Vortag:
$7.13
Offen:
$7.16
24-Stunden-Volumen:
1.76M
Relative Volume:
0.46
Marktkapitalisierung:
$1.74B
Einnahmen:
$407.32M
Nettoeinkommen (Verlust:
$-61.60M
KGV:
-27.29
EPS:
-0.2576
Netto-Cashflow:
$-43.98M
1W Leistung:
+16.68%
1M Leistung:
+17.46%
6M Leistung:
+24.11%
1J Leistung:
+77.52%
1-Tages-Spanne:
$6.99
$7.39
1-Wochen-Bereich:
$6.00
$7.43
52-Wochen-Spanne:
$3.21
$8.40
Ardelyx Inc Stock (ARDX) Company Profile
Firmenname
Ardelyx Inc
Sektor
Branche
Telefon
510-745-7047
Adresse
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
7.03 | 1.76B | 407.32M | -61.60M | -43.98M | -0.2576 |
VRTX
Vertex Pharmaceuticals Inc
|
425.06 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.63 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
809.16 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
302.47 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.76 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-09-03 | Fortgesetzt | Raymond James | Strong Buy |
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-05-02 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2025-03-04 | Eingeleitet | BTIG Research | Buy |
| 2024-11-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-18 | Eingeleitet | Raymond James | Strong Buy |
| 2023-09-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-08-25 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2022-11-17 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Herabstufung | Jefferies | Buy → Hold |
| 2021-07-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-03-23 | Eingeleitet | Wedbush | Outperform |
| 2021-01-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Fortgesetzt | Citigroup | Buy |
| 2020-02-18 | Fortgesetzt | Jefferies | Buy |
| 2020-02-12 | Eingeleitet | Citigroup | Buy |
| 2020-02-10 | Eingeleitet | Cowen | Outperform |
| 2019-04-08 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-08-24 | Eingeleitet | Jefferies | Buy |
| 2018-03-19 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-11-29 | Bestätigt | Citigroup | Buy |
| 2017-11-22 | Bestätigt | Ladenburg Thalmann | Buy |
| 2017-10-17 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-03-31 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2016-03-09 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2016-03-03 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Ardelyx Inc Aktie (ARDX) Neueste Nachrichten
ARDX SEC FilingsArdelyx 10-K, 10-Q, 8-K Forms - Stock Titan
Ardelyx (NASDAQ:ARDX) Strengthens Amid Biotech Momentum - Kalkine Media
Ardelyx, Inc. (NASDAQ:ARDX) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - 富途牛牛
Earnings Update: Ardelyx, Inc. (NASDAQ:ARDX) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - simplywall.st
Ardelyx reiterates 2026 guidance as IBSRELA targets $1B in 2029 while advancing ACCEL CIC Phase III enrollment by year-end - MSN
A Look At Ardelyx (ARDX) Valuation After Strong Q1 Results And Updated 2026 Guidance - simplywall.st
Analyst Estimates: Here's What Brokers Think Of Ardelyx, Inc. (NASDAQ:ARDX) After Its First-Quarter Report - Yahoo Finance
AIGH Capital Management LLC Purchases 951,500 Shares of Ardelyx, Inc. $ARDX - MarketBeat
Ardelyx Projects $1 Billion Revenue for Ibsrela by 2029 - HarianBasis.co
Ardelyx Earnings Call: Ibsrela Surge Fuels Bold Targets - TipRanks
Piper Sandler Maintains Ardelyx(ARDX.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Ardelyx Posts Strong Q1 2026 Revenue, Reaffirms Guidance - The Globe and Mail
Ardelyx (ARDX) Is Up 6.2% After Revenue Rises And Loss Narrows As New CLO Joins - simplywall.st
Ardelyx | 8-K: Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update - Moomoo
Ardelyx | 10-Q: Q1 2026 Earnings Report - Moomoo
Ardelyx (NASDAQ:ARDX) Shares Gap Down After Earnings Miss - MarketBeat
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2026 Earnings Call Transcript - Insider Monkey
Ardelyx (ARDX) Q1 2026 Earnings Transcript - AOL.com
Analyst Reiterates Buy on Ardelyx, Citing Tenapanor Momentum and Pipeline Upside with Unchanged $18 Price Target - TipRanks
MSN Money - MSN
Earnings Call Summary | Ardelyx(ARDX.US) Q1 2026 Earnings Conference - Moomoo
Ardelyx (NASDAQ:ARDX) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Ardelyx, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Ardelyx (ARDX) Reports Strong Q1 Revenue and Strategic Developme - GuruFocus
ARDX: Q1 revenue up 38% year-over-year, driven by IBSRELA and XPHOZAH growth, with guidance reaffirmed - TradingView
Ardelyx (ARDX) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Ardelyx (ARDX) Reports Mixed Q1 Earnings with Revenue Beat - GuruFocus
Ardelyx Q1 Earnings Call Highlights - Yahoo Finance
Compared to Estimates, Ardelyx (ARDX) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
ARDX: Q1 2026 delivered robust 38% revenue growth, driven by IBSRELA and XPHOZAH performance - TradingView
Is Ardelyx (ARDX) Undervalued After Q1 2026? GAAP EPS -$0.15 Mis - GuruFocus
Earnings call transcript: Ardelyx Q1 2026 misses forecasts but shows growth - Investing.com India
Earnings Flash (ARDX) Ardelyx Posts Q1 EPS -$0.15, vs. FactSet Est of -$0.14 - marketscreener.com
Ardelyx Inc (NASDAQ:ARDX) Reports Strong Q1 Revenue Beat as IBSRELA Momentum Accelerates - ChartMill
ARDELYX ($ARDX) Releases Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (ARDX) Ardelyx, Inc. Reports Q1 Revenue $94.5M - marketscreener.com
Ardelyx: Q1 Earnings Snapshot - Barchart
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update - The Manila Times
Ardelyx says IBSRELA sales hit $70.1M as it funds new trials - Stock Titan
ARDELYX, INC. 1Q 2026: Revenue $94.5M, EPS $(0.15) — 10-Q Summary - TradingView
Ardelyx (NASDAQ: ARDX) grows Q1 2026 sales but remains unprofitable - Stock Titan
Ardelyx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[8-K] ARDELYX, INC. Reports Material Event - Stock Titan
Ardelyx, Inc. Reiterates Revenue Guidance for Full Year 2026 - marketscreener.com
Ardelyx Target of Unusually Large Options Trading (NASDAQ:ARDX) - MarketBeat
Ardelyx earnings on deck: Can IBSRELA growth offset losses? By Investing.com - Investing.com Nigeria
Ardelyx earnings on deck: Can IBSRELA growth offset losses? - Investing.com UK
Ardelyx Inc (ARDX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments By GuruFocus - Investing.com Canada
Ardelyx gains after insider purchase, LPGA marketing deal - MSN
New equity plan shares and pay votes at Ardelyx (NASDAQ: ARDX) 2026 meeting - Stock Titan
ARDX Q1'26 Earnings: EPS estimate is (0.14) USD - TradingView
Finanzdaten der Ardelyx Inc-Aktie (ARDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.78%
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):